Technical Analysis for PMVP - PMV Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.61 | 2.23% | 0.04 |
PMVP closed down 1.26 percent on Wednesday, November 20, 2024, on 56 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 2.23% | |
| Stochastic Buy Signal | Bullish | 2.23% | |
| Oversold Stochastic | Weakness | 2.23% | |
| Crossed Above 50 DMA | Bullish | 0.94% | |
| Oversold Stochastic | Weakness | 0.94% | |
| 20 DMA Resistance | Bearish | 2.88% | |
| Fell Below 50 DMA | Bearish | 2.88% | |
| Gapped Up | Strength | 2.88% | |
| Oversold Stochastic | Weakness | 2.88% | |
| 20 DMA Resistance | Bearish | -0.31% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 2 hours ago |
| 10 DMA Resistance | about 2 hours ago |
| Up 5% | about 2 hours ago |
| Up 3% | about 2 hours ago |
| Up 1 ATR | about 2 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Cell Biology Proteins Apoptosis P53 Tumor Suppressor Genes
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Cell Biology Proteins Apoptosis P53 Tumor Suppressor Genes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.46 |
| 52 Week Low | 1.4 |
| Average Volume | 191,784 |
| 200-Day Moving Average | 1.67 |
| 50-Day Moving Average | 1.57 |
| 20-Day Moving Average | 1.65 |
| 10-Day Moving Average | 1.65 |
| Average True Range | 0.08 |
| RSI (14) | 44.44 |
| ADX | 30.19 |
| +DI | 20.62 |
| -DI | 18.48 |
| Chandelier Exit (Long, 3 ATRs) | 1.59 |
| Chandelier Exit (Short, 3 ATRs) | 1.77 |
| Upper Bollinger Bands | 1.76 |
| Lower Bollinger Band | 1.54 |
| Percent B (%b) | 0.15 |
| BandWidth | 13.56 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.02 |
| MACD Histogram | -0.0181 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.65 | ||||
| Resistance 3 (R3) | 1.64 | 1.62 | 1.63 | ||
| Resistance 2 (R2) | 1.62 | 1.60 | 1.62 | 1.63 | |
| Resistance 1 (R1) | 1.59 | 1.59 | 1.58 | 1.60 | 1.62 |
| Pivot Point | 1.57 | 1.57 | 1.56 | 1.57 | 1.57 |
| Support 1 (S1) | 1.54 | 1.55 | 1.53 | 1.55 | 1.52 |
| Support 2 (S2) | 1.52 | 1.54 | 1.52 | 1.51 | |
| Support 3 (S3) | 1.49 | 1.52 | 1.51 | ||
| Support 4 (S4) | 1.50 |
